Benitec Biopharma Inc. (BNTC) vs Fulcrum Therapeutics, Inc. (FULC)
A side-by-side comparison of Benitec Biopharma Inc. and Fulcrum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNTC
Benitec Biopharma Inc.
$8.87HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
FULC
Fulcrum Therapeutics, Inc.
$3.69HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — BNTC vs FULC
growth of $100 · dividends reinvested · last 7yBNTC -94.9% (-34.7%/yr)FULC -72.5% (-16.8%/yr)FULC compounded faster over this window
Log scale — wide-divergence pair
BNTC FULC
BNTC vs FULC: by the numbers
- •BNTC is the larger company ($305M vs $281M market cap).
Metrics side by side
Valuation
| Metric | BNTC | FULC |
|---|---|---|
| P/B ratio | 1.72 | 0.90 |
Profitability
| Metric | BNTC | FULC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -25.73% | -27.36% |
| ROIC | -28.88% | -27.62% |
Growth (annualized)
| Metric | BNTC | FULC |
|---|---|---|
| Total return CAGR (5Y) | -31.08% | -31.70% |
Frequently asked
- How have BNTC and FULC total returns compared?
- Over the past 5 years, BNTC delivered -31.08% and FULC delivered -31.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.